Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

Related Citations for PubMed (Select 23813452)

1.

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.

Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.

Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.

2.

Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.

Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.

Cerebrovasc Dis. 2013;36(4):273-80. doi: 10.1159/000353670. Epub 2013 Oct 16.

PMID:
24135809
3.

Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A.

Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.

PMID:
24610790
4.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

5.

Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.

Kornej J, Hindricks G, Banerjee A, Arya A, Sommer P, Rolf S, Husser D, Lip GY, Bollmann A.

Heart. 2015 Jan;101(2):126-31. doi: 10.1136/heartjnl-2014-306013. Epub 2014 Oct 3.

PMID:
25281600
6.

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.

Chua SK, Shyu KG, Lu MJ, Lien LM, Lin CH, Chao HH, Lo HM.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):919-926.e1. doi: 10.1016/j.jtcvs.2013.03.040. Epub 2013 Apr 26.

PMID:
23628495
7.

Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

Europace. 2014 Feb;16(2):195-201. doi: 10.1093/europace/eut244. Epub 2013 Sep 12.

8.

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.

Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.

PMID:
25546809
9.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

10.
11.

Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.

Apostolakis S, Lane DA, Buller H, Lip GY.

Thromb Haemost. 2013 Nov;110(5):1074-9. doi: 10.1160/TH13-07-0552. Epub 2013 Sep 19.

PMID:
24048467
12.

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

PMID:
22473219
13.

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.

Guo Y, Apostolakis S, Blann AD, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY.

Int J Cardiol. 2013 Sep 30;168(2):904-9. doi: 10.1016/j.ijcard.2012.10.052. Epub 2012 Nov 17.

PMID:
23167998
14.

CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemelä M, Lip GY, Airaksinen KE.

Thromb Res. 2014 Apr;133(4):560-6. doi: 10.1016/j.thromres.2014.01.007. Epub 2014 Jan 11.

PMID:
24461143
15.

CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.

Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, Savvari P, Manios E, Milionis H, Vemmos K.

Neurology. 2013 Mar 12;80(11):1009-17. doi: 10.1212/WNL.0b013e318287281b. Epub 2013 Feb 13.

PMID:
23408865
16.

R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.

Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA.

Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.

PMID:
24582725
17.

Prolonged atrium electromechanical interval is associated with stroke in patients with atrial fibrillation after catheter ablation.

Chao TF, Lin YJ, Tsao HM, Chang SL, Lo LW, Hu YF, Tuan TC, Li CH, Chang HY, Wu TJ, Yu WC, Chen SA.

J Cardiovasc Electrophysiol. 2013 Apr;24(4):375-80. doi: 10.1111/jce.12054. Epub 2012 Dec 17.

PMID:
23252831
18.

Predictive value of thromboembolic risk scores before an atrial fibrillation ablation procedure.

Floria M, De Roy L, Xhaet O, Blommaert D, Jamart J, Gerard M, Dormal F, Deceuninck O, Ambarus V, Marchandise B, Schroeder E.

J Cardiovasc Electrophysiol. 2013 Feb;24(2):139-45. doi: 10.1111/j.1540-8167.2012.02442.x. Epub 2012 Oct 15.

PMID:
23066657
19.

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.

Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.

PMID:
23572113
20.

Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?

Abraham JM, Larson J, Chung MK, Curtis AB, Lakshminarayan K, Newman JD, Perez M, Rexrode K, Shara NM, Solomon AJ, Stefanick ML, Torner JC, Wilkoff BL, Wassertheil-Smoller S.

Am J Med. 2013 Dec;126(12):1143.e1-8. doi: 10.1016/j.amjmed.2013.05.023. Epub 2013 Oct 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk